Expression of angiogenic factors and structural proteins in central nervous system vascular malformations

Neurosurgery

Volumn 38, Issue 5, 1996, Pages 915-925

  Rothbart, David ^a   Awad, Issam A ^a   Lee, Jiyon ^a   Kim, Jung ^a   Harbaugh, Robert ^b   Criscuolo, Gregory R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Arteriovenous malformations; bF GF; Cavernous malformations; Matrix proteins; VFGF

Indexed keywords

ALPHA ACTIN; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 4; FIBRONECTIN; LAMININ; SCLEROPROTEIN; STRUCTURAL PROTEIN; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; CAVERNOUS SINUS; CLINICAL ARTICLE; CLINICAL FEATURE; DURA MATER; EPILEPSY; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; MALE; PARAPLEGIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ACTINS; ADOLESCENT; ADULT; ANGIOGENESIS INDUCING AGENTS; BRAIN; COLLAGEN; DURA MATER; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GENES; HUMANS; IMMUNOENZYME TECHNIQUES; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; LYMPHOKINES; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029865645     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199605000-00011     Document Type: Article

References (54)

1. Awad IA, Robinson JJ, Mohanty S, Estes ML: Mixed vascular malformations of the brain: Clinical and pathogenetic considerations. Neurosurgery 33:179-188, 1993.
2. Barsky SH, Rao NC, Restrepo C, Liotta LA: Immunocytochemical enhancement of basement membrane antigens by pepsin: Applications in diagnostic pathology. Am J Clin Path 82:191-194, 1984.
3. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH: Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91:153-159, 1993.
4. Bobik A, Campbell JH: Vascular derived growth factors: Cell biology, pathophysiology, and pharmacology. Pharm Rev 45:1-42, 1993.
5. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh D: Integrin alpha-v beta-3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164, 1994.
6. Bruce JN, Criscuolo GR, Merrill MJ, Moquin RR, Blacklock JB, Oldfield EH: Vascular permeability induced by protein product of malignant brain tumors: Inhibition by dexamethasone. J Neurosurg 67:880-884, 1987.
7. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familetti PC, Pan YC, Olander JV, Connolly DT, Stern D: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 172:1535-1545, 1990.
8. Coffin JD, Poole TJ: Embryonic vascular development: Immunohistochemical identification of the origin and subsequent morphogenesis of the major vessel primordia in quail embryos. Development 102:735-748, 1988.
9. 8a. Comair Y, Rhoten P, de la Motte C, Awad I, DiCorleto P: Isolation and characterization of endothelial cells in vascular malformations. Presented at the 62nd Annual Meeting of the American Association of Neurological Surgeons, San Diego, April 1994.
10. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478, 1989.
11. Criscuolo GR: The genesis of peritumoral vasogenic brain edema and tumor cysts: A hypothetical role for tumor-derived vascular permeability factor. Yale J Biol Med 66:277-314, 1993.
12. Criscuolo GR, Lelkes PI, Rotrosen D, Oldfield EH: Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity. J Neurosurg 71:884-891, 1989.
13. Criscuolo GR, Merrill MJ, Oldfield EH: Further characterization of malignant glioma-derived vascular permeability factor. J Neurosurg 69:254-262, 1988.
14. Dejana E, Lampugnani MG, Giorgi M, Gaboli M, Marchisio PC: Fibrinogen induces endothelial cell adhesion and spreading via the release of endogenous matrix proteins and the recruitment of more than one integrin receptor. Blood 75:1509-1517, 1990.
15. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991, 1992.
16. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858, 1989.
17. Folkman J, Klagsburn M: Angiogenic factors. Science 235:442-447, 1987.
18. Garbisa S, Negro A: Macromolecular organization and functional architecture of basement membranes. Appl Path 2:217-222, 1984.
19. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86:7311-7315, 1989.
20. Gospodarowicz D, Ferrara N, Haaparanta T, Neufeld G: Basic fibroblast growth factor: Expression in cultured bovine vascular smooth muscle cells. Eur J Cell Biol 46:144-151, 1988.
21. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G: Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8:95-114, 1987.
22. Gunel M, Awad I, Anson J, Lifton R: Mapping of a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A 92:6620-6624, 1995.
23. Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M: Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: An immunohistochemical study. J Neurosurg 75:267-270, 1991.
24. Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara N: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244-253, 1992.
25. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309-1312, 1989.
26. Keep RF, Jones HC: Cortical microvessels during brain development: A morphometric study in the rat. Microvasc Res 40:412-426, 1990.
27. Kittelberger R, Davis PF, Stehbens WE: Distribution of Type IV collagen, laminin, nidogen and fibronectin in the haemodynamically stressed vascular wall. Histol Histopathol 5:161-167, 1990.
28. Krum JM, More NS, Rosenstein JM: Brain angiogenesis: Variations in vascular basement membrane glycoprotein immunoreactivity. Exp Neurol 111:152-165, 1991.
29. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309, 1989.
30. Liakka A, Apaja SM, Karttunen T, Autio HH: Distribution of laminin and Types IV and III collagen in fetal, infant and adult human spleens. Cell Tissue Res 263:245-252, 1991.
31. Little JR, Awad IA, Jones SC, Ebrahim ZY: Vascular pressures and cortical blood flow in cavernous angioma of the brain. J Neurosurg 73:555-559, 1990.
32. Mauro A, Bertolotto A, Germano I, Giaccone G, Giordana MT, Migheli A, Schiffer D: Collagenase in the immunohistochemical demonstration of laminin, fibronectin and factor VIII/RAg in nervous tissue after fixation. Histochemistry 80:157-163, 1984.
33. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, McCormick MK, Pericak-Vance MA, Heutnik P, Oostra BA, Haitjema T, Westerman CJJ, Porteous ME, Guttmacher AE, Letarte M, Marchuk DA: Endoglin, a TGF-β-binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia Type 1. Nat Genet 8:345-351, 1994.
34. Merei FT, Gallyas F, Horvath Z: Elastic elements in the media and adventitia of human intracranial extracerebral arteries. Stroke 11:329-335, 1980.
35. Myoken Y, Kayada Y, Okamoto T, Kan M, Sato GH, Sato JD: Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci U S A 88:5819-5823, 1991.
36. Navaratnam V: Organisation and reorganisation of blood vessels in embryonic development. Eye 5:147-150, 1991.
37. Paulus W, Grothe C, Sensenbrenner M, Janet T, Baur I, Graf M, Roggendorf W: Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors. Acta Neuropathol (Berl) 79:418-423, 1990.
38. Rifkin DB, Moscatelli D: Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109:1-6, 1989.
39. Risau W: Angiogenic growth factors. Prog Growth Factor Res 2:71-79, 1990.
40. Risau W, Lemmon V: Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol 125:441-450, 1988.
41. Robinson JJ, Awad IA, Masaryk TJ, Estes ML: Pathological heterogeneity of angiographically occult vascular malformations of the brain. Neurosurgery 33:547-554, 1993.
42. Robinson JR, Awad IA, Zhou P, Barna BP, Estes ML: Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: Preliminary observations and working hypothesis. Neurol Res 17:49-58, 1995.
43. Schultz GS, Grant MB: Neovascular growth factors. Eye 5:170-180, 1991.
44. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D: Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325:257-259, 1987.
45. Senger DR, Connolly DT, Van De Water L, Feder J, Dvorak HF: Purification and NH2-terminal amino acid sequence of guinea pig tumor secreted vascular permeability factor. Cancer Res 50:1774-1778, 1990.
46. Senger DR, Perruzzi CA, Feder J, Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629-5632, 1986.
47. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992.
48. Strugar JG, Criscuolo GR, Rothbart D, Harrington W: Vascular endothelial growth/permeability factor expression in human glioma specimens: Correlation with vasogenic brain edema and tumor-associated cysts. J Neurosurg 83:682-689, 1995.
49. Strugar J, Rothbart D, Harrington W, Criscuolo GR: Vascular permeability factor in brain metastases: Correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 81:560-566, 1994.
50. Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H, Hatanaka M: Gene expression of fibroblast growth factors in human gliomas and meningiomas: Demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci U S A 87:5710-5714, 1990.
51. Takahashi K, Mulliken JB, Kozakewich HPW: Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 93:2357-2364, 1994.
52. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954, 1991.
53. Tsuboi R, Sato Y, Rifkin DB: Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells. J Cell Biol 110:511-517, 1990.
54. Vlodavsky I, Fuks Z, Ishai MR, Bashkin P, Levi E, Korner G, Bar Shavit R, Klagsburn M: Extracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis. J Cell Biochem 45:167-176, 1991.